Novo Nordisk investment to create hundreds of jobs

Christian Wenande
November 4th, 2015

This article is more than 8 years old.

Pharm company to invest 2.1 billion kroner in a new insulin filling facility in Hillerød

Hard to tell whether the flag is at half-mast (photo: Novo Nordisk)

Novo Nordisk has revealed plans to invest 2.1 billion kroner in a new insulin filling facility in a move that is expected to generate 450 new jobs.

The filling facility will consist of 10,300 square metres and will be located just north of Copenhagen in Hillerød, where the company already employs some 1,900 people.

“The investment in Hillerød underscores our long-term ambition to create and maintain jobs in Denmark. This year alone we have created 1,000 new jobs in Denmark, of which 500 are in production, primarily in Kalundborg and Hillerød,” said Henrik Wulff, the executive vice president and head of Novo Nordisk’s product supply division.

READ MORE: Novo Nordisk to invest billions into US factory

Year for investment
The new facility in Hillerød will be charged with filling the pharmaceutical giant’s current and future insulin products.

The news comes in the wake of several investments this year, including a billion-kroner facility in the US and a new haemophilia facility in Kalundborg.


Subscribe to our newsletter

Sign up to receive The Daily Post

Latest Podcast